Validation of the Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex

ABSTRACT Background There is a lack validated outcome measures to assess wound severity in epidermolysis bullosa simplex (EBS). Objectives To assess the reliability and validity of the Investigator's Global Assessment (IGA) scale and a newly developed palms/soles subscale through in‐clinic scoring and review of patient‐submitted photographs. Methods Seven eligible patients with biopsy‐proven or genetically confirmed diagnosis of EBS were recruited. Seven expert raters graded 30 wounds at a 1‐day in‐clinic scoring exercise using an IGA scale that was previously developed for assessing wound severity in EBS clinical trials. A new palms/soles subscale was developed by the authors for palms and soles wounds. Reliability and construct validity with the Epidermolysis Bullosa Disease Activity and Scarring Index‐Activity (EBDASI‐Activity) subscore, target wound blister count, the Quality of Life in Epidermolysis Bullosa (QOL‐EB) questionnaire, itch and pain measures were assessed. Photographs of the same wounds provided by the patients were sent to the same raters to evaluate intra‐rater reliability through a virtual exercise. Results Seven clinicians with EB expertise assessed 30 target wounds. Patients (female n = 5/7) had a mean age of 28.3 years (range 7.1–48.8 years). Strong inter‐rater reliability was observed for the in‐clinic scoring (Kendall's coefficient of concordance, 0.77; intraclass coefficient, 0.70) with excellent agreement (weighted quadratic kappa, 0.86). A positive association with target wound blister count, EBDASI‐Activity, and itch and pain scores were observed. Home photograph scoring also showed strong inter‐rater reliability and excellent agreement (Kendall's coefficient of concordance, 0.78; weighted quadratic kappa, 0.84; intraclass coefficient, 0.66). When home‐photograph scores were compared to in‐clinic scores rendered on corresponding wounds, strong intra‐rater and substantial agreement was demonstrated (Kendall's coefficient of concordance, 0.86; weighted quadratic kappa, 0.67; intraclass coefficient, 0.68). Conclusions The IGA scale for EBS demonstrated strong reliability and excellent agreement in assessing wound severity of target lesions both in‐clinic and via patient‐submitted photographs.

Authors

Institutions

Publication Details

Journal
JEADV Clinical Practice
Published
2026-07-02
DOI
https://doi.org/10.1002/jvc2.70373
Primary Topic
Skin and Cellular Biology Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of the Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex

Lila Perrone, Joyce Teng, Austin Johnson, Pirunthan Pathmarajah et al.
JEADV Clinical Practice
Skin and Cellular Biology Research
article

Validation of the Investigator's Global Assessment Scale for Epidermolysis Bullosa Simplex

Lila Perrone, Joyce Teng, Austin Johnson, Pirunthan Pathmarajah, S. Li, D. Mitchell, R. Villanueva Gaona, Shehla Admani, Edward Eid, M. Peter Marinkovich, Jean Y. Tang, Maya B. Mathur, Joanna Tu, Albert S. Chiou
article en

Abstract

ABSTRACT Background There is a lack validated outcome measures to assess wound severity in epidermolysis bullosa simplex (EBS). Objectives To assess the reliability and validity of the Investigator's Global Assessment (IGA) scale and a newly developed palms/soles subscale through in‐clinic scoring and review of patient‐submitted photographs. Methods Seven eligible patients with biopsy‐proven or genetically confirmed diagnosis of EBS were recruited. Seven expert raters graded 30 wounds at a 1‐day in‐clinic scoring exercise using an IGA scale that was previously developed for assessing wound severity in EBS clinical trials. A new palms/soles subscale was developed by the authors for palms and soles wounds. Reliability and construct validity with the Epidermolysis Bullosa Disease Activity and Scarring Index‐Activity (EBDASI‐Activity) subscore, target wound blister count, the Quality of Life in Epidermolysis Bullosa (QOL‐EB) questionnaire, itch and pain measures were assessed. Photographs of the same wounds provided by the patients were sent to the same raters to evaluate intra‐rater reliability through a virtual exercise. Results Seven clinicians with EB expertise assessed 30 target wounds. Patients (female n = 5/7) had a mean age of 28.3 years (range 7.1–48.8 years). Strong inter‐rater reliability was observed for the in‐clinic scoring (Kendall's coefficient of concordance, 0.77; intraclass coefficient, 0.70) with excellent agreement (weighted quadratic kappa, 0.86). A positive association with target wound blister count, EBDASI‐Activity, and itch and pain scores were observed. Home photograph scoring also showed strong inter‐rater reliability and excellent agreement (Kendall's coefficient of concordance, 0.78; weighted quadratic kappa, 0.84; intraclass coefficient, 0.66). When home‐photograph scores were compared to in‐clinic scores rendered on corresponding wounds, strong intra‐rater and substantial agreement was demonstrated (Kendall's coefficient of concordance, 0.86; weighted quadratic kappa, 0.67; intraclass coefficient, 0.68). Conclusions The IGA scale for EBS demonstrated strong reliability and excellent agreement in assessing wound severity of target lesions both in‐clinic and via patient‐submitted photographs.

JEADV Clinical Practice
Veterans Health Administration (US), Stanford University (US)
Openalex Percentile: Top 9%
Skin and Cellular Biology Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.